Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-16-000899
Filing Date
2016-11-03
Accepted
2016-11-03 13:23:02
Documents
24
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin1026form10q.htm 10-Q 128587
2 EXHIBIT 31.1 skin1026form10qexh31_1.htm EX-31.1 8351
3 EXHIBIT 31.2 skin1026form10qexh31_2.htm EX-31.2 8370
4 EXHIBIT 32.1 skin1026form10qexh32_1.htm EX-32.1 4292
  Complete submission text file 0001554795-16-000899.txt   539791

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20160930.xml EX-101.INS 28177
6 XBRL SCHEMA FILE skin-20160930.xsd EX-101.SCH 6562
7 XBRL CALCULATION FILE skin-20160930_cal.xml EX-101.CAL 15635
8 XBRL DEFINITION FILE skin-20160930_def.xml EX-101.DEF 4571
9 XBRL LABEL FILE skin-20160930_lab.xml EX-101.LAB 59170
10 XBRL PRESENTATION FILE skin-20160930_pre.xml EX-101.PRE 40119
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 161970951
SIC: 6770 Blank Checks